Ambulatory Blood Pressure. An Independent Predictor of Prognosis in Essential Hypertension
|
|
- William Blankenship
- 5 years ago
- Views:
Transcription
1 793 Ambulatory Blood Pressure An Independent Predictor of Prognosis in Essential Hypertension Paolo Verdecchia, Carlo Porcellati, Giuseppe Schillaci, Claudia Borgioni, Antonella Ciucci, Massimo Battistelli, Massimo Guerrieri, Camillo Gatteschi, Ivano Zampi, Antonella Santucci, Carla Santucci, Gianpaolo Reboldi Abstract To determine the prognostic significance of ambulatory blood pressure, we prospectively followed for up to 7.5 years (mean, 3.2) 1187 subjects with essential hypertension and 205 healthy normotensive control subjects who had baseline off-therapy 24-hour noninvasive ambulatory blood pressure monitoring. Prevalence of white coat hypertension, defined by an average daytime ambulatory blood pressure lower than 131/86 mm Hg in women and 136/87 mm Hg in men in clinically hypertensive subjects, was 19.2%. Cardiovascular morbidity, expressed as the number of combined fatal and nonfatal cardiovascular events per 100 patient-years, was 0.47 in the normotensive group, 0.49 in the white coat hypertension group, 1.79 in dippers with ambulatory hypertension, and 4.99 in nondippers with ambulatory hypertension. After adjustment for traditional risk markers for cardiovascular disease, morbidity did not differ between the normotensive and white coat hypertension groups (P=.83). Compared with the white coat hypertension group, cardiovascular morbidity increased in ambulatory hypertension in dippers (relative risk, 3.70; 95% confidence interval, 1.13 to 12.5), with a further increase of Target-organ damage in essential hypertension is more closely associated with ambulatory than with clinic blood pressure (BP), 1-3 and for any given value of clinic BP it is directly related to the mean levels 45 and variability 5-6 of ambulatory BP. Since targetorgan damage is a powerful predictor of morbidity and mortality in hypertension, 7 -' 6 ambulatory BP might offer prognostic information beyond that provided by clinic BP. Only one large prospective study, based on daytime ambulatory BP readings, has been published concerning the prognostic significance of ambulatory BP in essential Received May 24, 1994; accepted in revised form August 5, From Ospedale Generale Regionale "R. Silvestrini," Unita Organica di Malattie Cardiovascolari e Medicina Interna (P.V., C.P., C.B., A.C., M.B., C.G., I.Z.); Ospedale "Beato G. Villa," Citta delta Pieve (G.S.); Ospedale "S. Agostino," Castiglione del Lago (M.G.); Cattedra di Statistica e Biometria, Istituto di Medicina Interna e Medicina Vascolare delpuniversita di Perugia (A.S., C.S.); and Istituto di Medicina Interna e Scienze Endocrine e Metaboliche dell'universita di Perugia (G.R.) (Italy). Presented in part at the 15th Scientific Meeting of the International Society of Hypertension, Melbourne, Australia, March 1994, and at the Ninth Annual Scientific Meeting of the American Society of Hypertension, New York, NY, May Reprint requests to Dr Paolo Verdecchia, Ospedale Generale Regionale "R. Silvestrini," Unita Organica di Malattie Cardiovascolari e Medicina Interna, Localita San Sisto, Perugia PG, Italy American Heart Association, Inc. morbidity in nondippers (relative risk, 6.26; 95% confidence interval, 1.92 to 20.32). After adjustment for age, sex, diabetes, and echocardiographic left ventricular hypertrophy (relative risk versus subjects with normal left ventricular mass, 1.82; 95% confidence interval, 1.02 to 3.22), cardiovascular morbidity in ambulatory hypertension was higher (P=.0002) in nondippers than in dippers in women (relative risk, 6.79; 95% confidence interval, 2.45 to 18.82) but not in men (P=.9\). Our findings suggest that ambulatory blood pressure stratifies cardiovascular risk in essential hypertension independent of clinic blood pressure and other traditional risk markers including echocardiographic left ventricular hypertrophy. Cardiovascular morbidity is low in white coat hypertension and exceedingly high in women with ambulatory hypertension and absent or blunted blood pressure reduction from day to night. (Hypertension. 1994;24: ) Key Words blood pressure monitoring, ambulatory hypertension, essential prognosis hypertrophy, left ventricular mortality morbidity echocardiography hypertension On the other hand, an association between nighttime BP and target-organ damage, reflecting the potential detrimental effect of a persistent pressure overload, has been shown in several cross-sectional studies. 619 " 23 In a small case-control study, we found preliminary evidence of a blunted nocturnal reduction of BP in hypertensive women, but not in men, with a major cardiovascular event over the subsequent years. 24 Moreover, a history of stroke is more frequent in subjects with an absent or blunted nocturnal fall in BP than in those with normal diurnal BP rhythm. 25 In 1986 we started the Progetto Ipertensione Umbria Monitoraggio Ambulatoriale (PIUMA) study, a registry of morbidity and mortality in subjects with essential hypertension whose initial off-therapy diagnostic workup included 24-hour ambulatory BP monitoring according to a standardized protocol. The results of this study are reported here. Methods Study Population The study population was composed of 1187 subjects diagnosed with essential hypertension who entered the PIUMA registry from June 1986 to July 1993 in three participating Hospitals (Perugia, Citta della Pieve, Castiglione del Lago). Admission criteria to the PIUMA registry included all of the following: (1) essential hypertension with sitting BP greater than or equal to 140 mm Hg systolic or 90 mm Hg diastolic on
2 794 Hypertension Vol 24, No 6 December 1994 at least three visits in the previous 3 weeks; (2) any previous antihypertensive drugs withdrawn for at least 4 weeks; (3) agreement within 5 mm Hg between a mercury column and automatic recorder in at least three consecutive BP measurements taken simultaneously on the same arm before ambulatory BP monitoring was begun; (4) at least one valid ambulatory BP reading per hour for the entire 24-hour period; and (5) absence of heart failure, valvular defects, or concomitant important disease. Previous cardiovascular events were not exclusion criteria from the study for subjects maintaining their full physical and working activities. The initial evaluation in the PIUMA study included a detailed medical history, a 12-lead electrocardiogram, a funduscopic evaluation, screening laboratory tests (serum urea nitrogen, serum creatinine, serum glucose, serum uric acid, serum cholesterol, serum sodium, potassium and calcium, and urinalysis), and, from October 1987, routine standard and Doppler echocardiographic studies. Diabetes mellitus was defined by any one of the following: a fasting blood glucose level greater than or equal to 140 mg/dl, a random nonfasting blood glucose level greater than or equal to 200 mg/dl, or the use of an oral hypoglycemic agent or insulin. A cohort of 205 healthy normotensive subjects composed of members of the hospital staff, medical students, or training fellows (n=98) or subjects examined in our echocardiography laboratories for reasons different from hypertension (innocent systolic murmurs, palpitations, general checkup) volunteered to undergo the laboratory procedures established in the PIUMA registry and were included as a control group. To be eligible for inclusion, their clinic BP had to remain less than 140/90 mm Hg for at least three visits over a 3-week period in the absence of any treatment. All subjects gave informed consent to the study, which was conducted in accordance with the declarations of Helsinki and Tokyo. Ambulatory BP Monitoring Ambulatory BP was recorded using the fully automatic SpaceLabs units 5200, 90202, and set to take a measurement every 15 minutes throughout the 24 hours. The reading, editing, and analysis of data provided by the recorders were done by the SpaceLabs ABP5600, ABP90204, and ABP90209 interfaces. readings greater than 260 mm Hg or less than 70 mm Hg, diastolic readings greater than 150 mm Hg or less than 40 mm Hg, and pulse pressure readings greater than 150 mm Hg or less than 20 mm Hg were automatically discarded. The daytime period was defined as the interval between 6 AM and 10 PM and the nighttime period as between 10 PM and 6 AM. The spontaneous day-to-day variability of 24-hour, daytime, and nighttime ambulatory BP values had previously been assessed in some of these subjects. 26 White coat hypertension was defined by a mean daytime ambulatory BP lower than 131/86 mm Hg in women and 136/87 mm Hg in men. These values are the 90th percentile of the distribution of daytime ambulatory BP in a normotensive population examined in our laboratory. 27 A previous study from our group showed that echocardiographic left ventricular (LV) mass, taken as a surrogate measure of outcome, 1216 is normal in clinically hypertensive subjects with mean daytime ambulatory BP below these values. 27 Nondippers were arbitrarily defined by a reduction in the mean systolic and diastolic BP values lower than 10% from day (6 AM to 10 PM) to night (10 PM to 6 AM), and the remaining subjects were classified as dippers. The division between dippers and nondippers was made on the basis of previous studies from our laboratory showing a different target-organ damage in the two groups Echocardiographic Study of the LV M-mode echocardiographic study of the LV was performed under cross-sectional control using commercially available machines according to standard laboratory procedures described previously Only tracings with optimal visualization of interfaces and showing simultaneous visualization of septum, LV internal diameter, and posterior wall were considered adequate for determination of LV mass. With the use of the formula introduced by Devereux et al, 29 LV mass in grams was calculated as 0.80xl.04x[(septal thickness+lv internal diameter+posterior wall thickness) 3 -(LV internal diameter) 3 ]+0.6 g and normalized by body surface area. The cutoff point for LV hypertrophy was 125 g/m 2 in both genders. This value has been validated in two prospective studies of the independent prognostic value of echocardiographic LV hypertrophy, one of which was carried out on a mixed population of men and women. 15 A division between absence and presence of LV hypertrophy at echocardiography may also be made using sex-specific height-adjusted values of LV mass, as done in the Framingham Heart Study A Cornell voltage score greater than 2.0 mv in women or 2.8 mv in men 30 defined LV hypertrophy by standard 12-lead electrocardiography. Clinical Follow-up After initial evaluation, all hypertensive subjects included in the PIUMA registry were followed-up in the outpatient clinic of the referring hospital or by their family doctors and were treated with the aim of reducing clinic BP below 140/90 mm Hg using standard lifestyle and pharmacological measures. The PIUMA protocol recommends that, in the absence of universally established normative values on ambulatory BP measures, therapeutic strategies should be based on clinic BP. Ambulatory BP reports remained accessible to patients and their doctors, but these data were unlikely to significantly influence therapeutic decisions, being generally considered as investigational findings of unproved clinical utility. Diuretics, /3-blockers, angiotensin-converting enzyme inhibitors, calcium channel blockers, and o,-blockers, alone or in various combinations, were the antihypertensive drugs most frequently used. Telephone interviews were conducted to ascertain the incidence of major complications of hypertension. All interviews were conducted directly with the subjects without knowledge of the results of ambulatory BP monitoring and were followed by a clinical visit whenever the subjects consented. The same procedures were performed in the control group. Periodic clinical visits could be performed in approximately 30% of hypertensive subjects. Hospital record forms were collegially reviewed by the authors of this study for the subjects who died from any cause or developed a major fatal or nonfatal cardiovascular event. Cardiovascular events included myocardial infarction, stroke, sudden death, angina pectoris, coronary revascularization, transient cerebral ischemic attack, aortoiliac occlusive disease, documented thrombotic occlusion of a retinal artery, and progressive cardiac or renal failure. Myocardial infarction was diagnosed on the basis of at least two of three standard criteria (typical chest pain, electrocardiographs QRS changes, transient elevation of myocardial enzymes by more than twofold the upper normal laboratory limits). Angina pectoris was defined by chest pain accompanied by typical ischemic changes on the electrocardiogram (1 mm of horizontal or downsloping ST depression during exercise test in the absence of digoxin and without ST depression at rest; 1 mm of horizontal or downsloping ST depression lasting 1 minute or longer during Holter monitoring). Sudden death was defined as a witnessed death that occurred within an hour after the onset of acute symptoms, with no history that violence or accident played any role in the fatal outcome. Stroke was diagnosed on the basis of rapid onset of localizing neurological deficit lasting 24 hours or longer in the absence of any other disease process explaining the symptoms. Transient ischemic attack was defined by the diagnosis, made by a physician, of any sudden focal neurological deficit that cleared completely in less than 24 hours. Statistical Analysis The outcome events studied were cardiovascular morbidity (fatal plus nonfatal events) and mortality. Event rates are
3 Verdecchia et al Prognostic Value of Ambulatory Blood Pressure 795 presented as the number of events per 100 patient-years based on the ratio of the observed number of events to the total number of patient-years of exposure. For subjects who experienced multiple nonfatal events, the analysis included only the first event. Survival curves were estimated using the Kaplan- Meier product-limit method 31 and compared by the Mantel (log-rank) test. 32 The effect of prognostic factors on survival was evaluated by the Cox semiparametric regression model. 33 The assumption of proportional hazards over time was verified before the analyses were performed and was met by all covariates. The assumption concerning linearity of continuous covariates was also verified before analysis. We pursued two lines of inquiry. First, we tested the independent significance of white coat hypertension in the entire cohort of normotensive and hypertensive subjects grouped into four categories: clinical normotension; white coat hypertension; ambulatory hypertension, dippers; and ambulatory hypertension, nondippers. The covariates included in the Cox model were age (<40 years, 40 to 60 years, >60 years), sex (men, women), clinic diastolic BP, clinic pulse pressure (to account for the levels of systolic BP), smoking habits (current smokers, previous smokers, never smokers), previous cardiovascular events (no, yes), diabetes mellitus (no, yes), serum cholesterol (<5.2 mmol/l, 5.2 to 6.5 mmol/l, >6.5 mmol/l), and body mass index (body weight in kilograms divided by height squared in meters [^27, >27]). LV hypertrophy was included either as electrocardiographic (no, yes) or echocardiographic (no, yes). Second, we tested the independent significance of the dippers-nondippers classification in the subset with ambulatory hypertension. Besides the above-mentioned covariates, average 24-hour ambulatory systolic and diastolic BP values were included in this model. All analyses including echocardiographic LV hypertrophy among the covariates were limited to the subset (n=1070) with adequate echocardiographic tracings for determination of LV mass. Adjusted relative risks (RR) for the significant Cox model factors were calculated as the antilogarithm of the b coefficient (e b i). Ninety-five percent confidence intervals (CI) around the RR estimate were obtained from the formula e (b ±1.96xSE tl[ ), where SE is the standard error of b,. In two-tailed tests, probability values less than.05 were considered statistically significant. SAS statistical software version 6.08 was used for analyses. Results Study Population We obtained complete follow-up data from 1380 of the 1392 subjects who entered the study from June 1986 to July 1993 (99.1%). The mean duration of follow-up was 3.2 years (range, 0.5 to 7.5). An echocardiographic study of the LV was attempted in 1233 subjects, and tracings were of adequate quality for determination of LV mass in 1070 (87%). Table 1 presents the clinical characteristics in the normotensive group, in the white coat hypertension group, and in dippers and nondippers with ambulatory hypertension. Prevalence of white coat hypertension was 19.2%. The distribution of antihypertensive treatments differed between the white coat hypertension and ambulatory hypertension groups (x 2 =56.6, P<.0001). In fact, 29% of subjects with white coat hypertension were under drug treatment, as opposed to 56% of subjects with ambulatory hypertension (nonpharmacological measures, diuretics or /3-blockers alone or combined, angiotensin-converting enzyme inhibitors or calcium antagonists alone or combined, various drug combinations and unknown treatments in 71%, 9%, 13%, 7%, and 0%, respectively, of subjects in the white coat group compared with 43%, 10%, 24%, 22%, and 1% of subjects in the ambulatory hypertension group). Table 2 shows the clinical characteristics in dippers and nondippers with ambulatory hypertension divided by gender. Cardiovascular Morbidity We documented 89 cardiovascular events (21 fatal and 68 nonfatal). Among fatal events, there were 10 strokes, 5 myocardial infarctions, and 6 sudden cardiac deaths. As for nonfatal events, there were 19 subjects with stroke, 7 with transitory ischemic attack, 10 with myocardial infarction, 8 with new-onset angina and ischemic electrocardiographic changes (3 of whom underwent coronary revascularization), 7 with new-onset congestive heart failure, 11 with aortoiliac occlusive disease, 2 with thrombotic occlusion of a retinal artery, and 4 with renal failure requiring dialysis. The distribution of antihypertensive treatments did not differ between the subjects who suffered a cardiovascular morbid event and those who did not (nonpharmacological measures, diuretics or j3-blockers alone or combined, angiotensin-converting enzyme inhibitors or calcium antagonists alone or combined, various drug combinations or unknown treatments in 52%, 9%, 24%, 15%, and 0%, respectively, in those with events versus 53%, 10%, 20%, 16%, and 1% in those without events; F=NS). As shown in Fig 1 (left), there were 4 events in the normotensive group (0.47 per 100 patient-years), 3 events in the white coat hypertension group (0.49 per 100 patient-years), 37 events in dippers with ambulatory hypertension (1.79 per 100 patient-years), and 45 events in nondippers with ambulatory hypertension (4.99 per 100 patient-years). Comparison between survival curves (Fig 1, right) was highly significant (/"<.0001). In the Cox analysis (Table 3), the risk of cardiovascular morbid events did not differ between the normotensive and white coat hypertension groups (P=.83). Compared with the white coat hypertension group, cardiovascular morbidity increased in ambulatory hypertension in dippers (RR, 3.70; 95% CI, 1.13 to 12.5), with a further increase of morbidity in nondippers (RR, 6.26; 95% CI, 1.92 to 20.32). These differences held after adjustment for the other significant covariates in the model including age, diabetes mellitus, previous cardiovascular events, and clinic pulse pressure. In contrast, clinic diastolic BP, smoking, serum cholesterol, body mass index, and electrocardiographic LV hypertrophy did not yield statistical significance. In the subset with available echocardiographic tracings, the risk associated with echocardiographic LV hypertrophy bordered on statistical significance (RR, 1.73; 95% CI, 0.98 to 3.04; />=.O57). Prevalence of LV hypertrophy at echocardiography among subjects with essential hypertension was 25.7%. The highest cardiovascular morbidity among subjects with echocardiographic LV hypertrophy occurred in nondippers with ambulatory hypertension; conversely, the lowest rate of events among subjects with normal LV mass occurred in the subjects with white coat hypertension (Fig 2). Therefore, cardiovascular risk stratification based on these three categories of ambulatory BP provided a stronger predictivity than stratification based on the two categories of presence and absence of echocardiographic LV hypertrophy. However, when the multivariate analysis was restricted to the subset with ambulatory hyperten-
4 796 Hypertension Vol 24, No 6 December 1994 TABLE 1. Baseline Characteristics of Essential Hypertensive and Normotensive Control Subjects Essential Hypertensive Subjects Characteristic n Mean age, y Male sex, % Diabetes mellitus, % Current smokers, % Previous cardiovascular events, % Body mass index, kg m~ 2 Clinic BP, mm Hg Mean 24-hour ambulatory BP, mm Hg Mean daytime ambulatory BP, mm Hg Mean nighttime ambulatory BP, mm Hg Serum cholesterol, mmol/l Serum triglycerides, mmol/l Serum glucose, mmol/l Serum uric acid, mmol/l Subset with adequate echocardiographic tracings n Interventricular septum thickness, cm LV internal diameter, cm Posterior wall thickness, cm LV mass, g rrr 2 Normotensive Subjects (15)*t 56 14* 27 Of 26(4) 126(9)*f 79(7)" 119(9)t 75(7)f 123 (9)t 79 (8)t 110(11)t 67 (8)t 5.22(1.06) 1.67 (0.94) 5.89(1.91) 268 (84)t (0.2)t 5.0 (0.5) 0.87 (0.1 )t 86(18)T BP indicates blood pressure; LV, left ventricular. Values are mean (SD). *P<.01 vs white coat hypertension. tp<.01 vs ambulatory hypertension, nondippers. *P<.01 vs normotensive controls. sion (Table 4), cardiovascular risk was higher in nondippers than in dippers in women (RR, 6.79; 95% CI, 2.45 to 18.82; / } =.0002) but not in men (P=.91) (Fig 3), and these differences held after adjustment for the other independent covariates in the model including age, sex, and echocardiographic LV hypertrophy (RR versus absence of hypertrophy, 1.82; 95% CI, 1.02 to 3.22; P=.O39). All the other risk markers for cardiovascular disease, including average 24-hour systolic and diastolic BP values, were not statistically significant. Cardiovascular Mortality Fig 4 shows survival curves for fatal cardiovascular events. There was only 1 event in the normotensive group, no events in the white coat hypertension group, White Coat Hypertension (12)t* 47 5t 22 2t 26(4) 145 (12)11: 91(7)t* 120 (7)f 76 (5)t 124 (6)t 79 (5)f 110 (10)t 67(7)t 5.39(1.18) 1.67(1.11) 5.56 (1.20)t 278 (78)t (0.2)t 5.0 (0.5) 0.88 (0.2)t 92 (24)t Ambulatory Hypertension Dippers (12)t* 49 7t* 24 2t 27(4) 159 (18)*t* 98(10)*$ 140(13)*t* 89 (8)** 145(13)*t* 93 (8)** 126(14)*t* 77 (9)*t* 5.58(1.06) 1.70(1.18) 5.59 (1.17)f* 280 (83)f (0.2)*t* 5.0 (0.5) 0.98 (0.2)*t* 109(32)*t* Nondippers (13)*t 52 17* 23 6** 27(4) 166(19)** 98(11)** 149(15)** 91 (10)** 150(15)** 93(10)** 146(16)** 88(10)** 5.55(1.19) 1.76(1.01)** 6.00 (1.69)* 303 (94)** (0.3)** 5.1 (0.6) 1.04 (0.2)** 122(32)** and 9 and 11 events, respectively, in dippers and nondippers with ambulatory hypertension. Comparison between survival curves (Fig 4) was highly significant (P<.002). Cardiovascular mortality could not be tested in the Cox multivariate analysis because the limited number of fatal events (n=21) precluded the inclusion in the model of more than two independent variables. 34 Discussion Ambulatory BP was an independent predictor of cardiovascular risk. Cardiovascular morbidity was lower in white coat than in ambulatory hypertension and not dissimilar between the white coat hypertension group and the normotensive group. Furthermore, it was higher
5 Verdecchia et al Prognostic Value of Ambulatory Blood Pressure 797 TABLE 2. Baseline Characteristics of Subjects with Ambulatory Hypertension Subdivided Into Dippers and Nondippers in Either Gender Men Women Characteristic n Mean age, y Diabetes mellitus, % Current smokers, % Previous cardiovascular events, % Body mass index, kg nt 2 Clinic BP, mm Hg Mean 24-hour ambulatory BP, mm Hg Mean daytime ambulatory BP, mm Hg Mean nighttime ambulatory BP, mm Hg Serum cholesterol, mmol/l Serum triglycerides, mmol/l Serum glucose, mmol/l Serum uric acid, mmol/l Subset with adequate echocardiographic tracings n Interventricular septum thickness, cm LV Internal diameter, cm Posterior wall thickness, cm LV mass, g m~ 2 BP Indicates blood pressure; LV, left ventricular. *P<.01 vs dippers. Dippers (12) (3) 156(18) 98(9) 141 (13) 90(8) 146(13) 95(8) 128(13) 79(9) 5.69(1.12) 1.56(1.28) 5.54(1.31) 242 (76) (0.3) 5.1 (0.5) 1.1 (0.2) 118(35) in nondippers than in dippers among women with ambulatory hypertension. White coat hypertension, defined by persistent clinic hypertension despite normal BP during usual daily life, may be the result of an alerting reaction associated with the clinic measurement of BP, 37 possibly leading to misclassiflcation of hypertension in some actually normotensive individuals Ambulatory BP 38 and self-measured BP 39 have been used to investigate the prevalence and clinical characteristics of white coat hypertension. In the absence of prospective studies, the normal ranges of variability of ambulatory and selfmeasured BP used to define white coat hypertension are currently derived from cross-sectional analyses of reference populations Echocardiographic LV mass, an independent prognostic predictor in this and other 1216 studies, is smaller in white coat than in ambulatory hypertension " 43 and similar in this and other studies, but not in all, 43 to that of healthy individuals Nondippers (11)* (4) 163(19)* 98(11) 150(14)* 93 (9)* 151 (14)* 95(10) 146(15)* 90 (9)* 5.60(1.07) 1.64(0.83) 6.15(2.04) 271 (89) (0.3) 5.3 (0.7) 1.1 (0.2) 124(32) Dippers (12) (4) 161 (18) 98(10) 139(12) 87(8) 144(13) 100(8) 125(15) 75(9) 5.46 (0.98) 1.84 (1.05) 5.63(1.02) 316(74) (0.2) 4.8 (0.5) 0.9 (0.2) 99 (26) Nondippers (14)* 22* * 27.1 (5) 169(19)* 97(11) 149(17)* 89(10) 149(16)* 91 (10) 146(18)* 86(10)* 5.50 (1.30) 1.86(1.14)* 5.85(1.22)* 335 (88)* (0.3)* 4.9 (0.5) 1.0 (0.2)* 120(33)* with normal clinic BP. Our findings provide prospective evidence that white coat hypertension, defined by an average daytime ambulatory BP less than 131/86 mm Hg in women or 136/87 mm Hg in men, is an independent predictor of low cardiovascular risk, even after adjustment for traditional risk markers for cardiovascular disease including, for example, clinic BP (which was lower in the white coat group than in the ambulatory hypertension group), age, diabetes, previous cardiovascular events, clinic pulse pressure, serum cholesterol, and echocardiographic LV hypertrophy. These results are consistent with preliminary data by Pickering 36 who reported a lower incidence of cardiovascular morbid events in clinically hypertensive subjects with white coat hypertension than in those with higher levels of ambulatory BP. The independent prognostic significance of clinic pulse pressure is consistent with the results of a recent prospective study. 44
6 798 Hypertension Vol 24, No 6 December 1994 I ~tc^ ^.^^! - NORMOTENSIVE WHITE COAT DIPPERS i O 0.7- i NON-DIPPERS S Q. J 5 S 0.6- o.o Duration of Follow-up (weeks) FIG 1. Graphs show incidence of major cardiovascular morbid events (left) and event-free survival (right) in the study population grotiped into the four categories of clinical normotension; wtiite coat hypertension; ambulatory hypertension, dippers; and ambulatory hypertension, nondippers. Comparison between survival curves was highly significant (P<.0001). 400 TABLE 3. Covariate Relative Risks for Cardiovascular Morbid Events in the Overall Population Overall population (n=1392) Ambulatory BP Age White coat hypertension vs clinical normotension Ambulatory hypertension, dippers vs white coat hypertension Ambulatory hypertension, nondippers vs white coat hypertension >60 vs <40 y vs <40 y Diabetes mellitus Present vs absent Previous cardiovascular events Present vs absent Clinic pulse pressure Continuous variable Subset with available echocardiographic tracings (n=1070) LV hypertrophy at echocardiography Present vs absent Cl indicates confidence interval; BP, blood pressure; and LV, left ventricular. There was a significant independent association between blunted nocturnal reduction of BP and cardiovascular morbidity in women, but not in men, with ambulatory hypertension. These results extend those of a smaller case-control analysis from the PIUMA registry. 24 The mechanisms by which a persistent pressure overload, expressed by a blunted nocturnal reduction in BP, may increase cardiovascular risk are incompletely understood. There is evidence of increased LV mass, " more advanced silent cerebrovascular damage, 21 and more frequent history of stroke 25 in hypertensive nondippers compared with dippers. Thus, for any given level of daytime BP, a persistent pressure overload might increase the progression of hypertensive organ damage and thereby predict a higher incidence of cardiovascular events. The greater cardiovascular risk in nondippers compared with dippers remained statistically significant after adjustment for the average 24-hour systolic and diastolic BP values. This removes the potential objection that the worse outcome in nondippers may be more closely associated with a higher average BP over the 24 hours than with an altered diurnal BP rhythm by itself. 45 In a previous reproducibility study, 26 73% of hypertensive patients remained in the same dipper/ nondipper category over two ambulatory sessions carried out 3 to 5 days apart, whereas the other 27% moved from one group to another. Relative Risk (95% CO 1.17( ) 3.70( ) 6.26 ( ) 7.11 ( ) 3.22( ) 2.02( ) 3.11 ( ) exp(0.013 x clinic pulse pressure) 1.73( )
7 Verdecchia et al Prognostic Value of Ambulatory Blood Pressure SUBJECTS 2 EVENTS 176 SUBJECTS 3 EVENTS 572 SUBJECTS 23 EVENTS 186 SUBJECTS 28 EVENTS «T 250 FIG 2. Scatterplots show baseline individual values of left ventricular mass in the subset of subjects with available echocardiographic tracings (n=1070) grouped into the four categories of clinical normotension; white coat hypertension; ambulatory hypertension, dippers; and ambulatory hypertension, nondippers. Filled circles show subjects who subsequently suffered a cardiovascular event : : :::: : : t i : t*: : : : 1 «1 I J I J L J L 4 :V: K " NORMOTENSIVE WHITE COAT AMBULATORY AMBULATORY COKTROLS HYPERTENSION HYPERTENSION HYPERTENSION DIPPERS NONDIPPERS Our study does not permit the elucidation of mechanisms by which the women with increased ambulatory BP, basically at lower cardiovascular risk than men, were most sensitive to the detrimental effect of a persistent compared with an intermittent pressure overload. Echocardiographic LV mass has been shown to be greater in hypertensive nondippers than in dippers only in women, 28-4 * as evidenced also in the present study, but the possible confounding effect of LV hypertrophy and other independent risk markers, particularly diabetes, old age, and previous cardiovascular events (all of which were more frequent in female nondippers), on the different cardiovascular risk in dippers and nondippers between the genders was accounted for in the Cox multivariate analysis. This study has two main limitations. First, only 30% of subjects had periodic visits during follow-up, so we could not assess the degree of BP control in a sufficiently large number of subjects. A multicenter prospective study designed to address this issue is currently ongoing in Italy. 47 Second, although the size of the study allowed a separate analysis for total and fatal cardiovascular events, it did not allow a further differentiation between cardiac, cerebrovascular, and peripheral vascular events. In general, because of the relatively low number of cardiovascular events (89 events), further assessment of the prognostic significance of ambulatory BP will need larger trials. The present study differs with regard to some methodological points from that by Perloff and coworkers, 171 * the only large study published so far on the prognostic value of ambulatory BP. Compared with the present study, that by Perloff and coworkers did not include a control normotensive group. Moreover, the availability of automated ambulatory BP recorders allowed us to estimate the entire 24-hour BP profile, whereas BP monitoring could not be performed during the night in the study of Perloff et al because of the use of manually activated recorders. Furthermore, serum cholesterol, cigarette smoking, and echocardiographic LV hypertrophy were tested as covariates only in the present study. Importantly, Perloff and coworkers did not attempt to define subjects with "normal" ambulatory BP (ie, white coat hypertension) but only hypertensive subsets at different cardiovascular risk. Overall, our findings and those by Perloff and coworkers indicate that ambulatory BP stratifies cardiovascular risk more accurately than TABLE 4. Relative Risks for Cardiovascular Morbid Events in the Subset Wtth Ambulatory Hypertension Covariate LV hypertrophy at echocardiography Age Sex Present vs absent >60 vs <40 y vs <40 y Men vs women Dipping pattern, nondippers vs dippers Men Women Cl indicates confidence Interval; LV, left ventricular. Relative Risk (95% Cl) 1.82 ( ) 8.04( ) 2.17( ) 4.16( ) 1.04( ) 6.79( ) P
8 800 Hypertension Vol 24, No 6 December _.. MEN DIPPERS NON-CHPPERS Duration of Follow-up (weeks) FIG 3. Graphs show event-free survival in men and women with essential hypertension and increased ambulatory blood pressure (ambulatory hypertension), subdivided into dippers and nondippers. Survival curves differed between dippers and nondippers in women (P<.001), but not in men (P=NS). clinic BP or other traditional cardiovascular risk factors in subjects with essential hypertension. It is currently believed that the indiscriminate use of ambulatory BP monitoring for all individuals with hypertension is not justified, 48 " 50 and our findings do not change this view for several reasons. First, our study included subjects never treated for hypertension or untreated for some weeks, and therefore our results cannot be extrapolated to subjects who are receiving antihypertensive treatment. Second, the present study included only white subjects. Third, our partition values are not yet standardized and need to be corroborated by other studies. Fourth, the clinical benefits of patient management based on ambulatory BP remain unexplored. Recognizing these arguments, we suggest from these findings that 24-hour ambulatory BP monitoring may be indicated in white untreated subjects with essential hypertension with two specific questions in mind. The first is the differentiation between white coat and ambulatory hypertension among subjects with persistent hypertension in the physician's office. A recent survey found that evaluation of white coat hypertension covers LOOT WHITE COAT Duration of Follow-up (woeks) FIG 4. Graph shows fatal cardiovascular event-free survival in the study population grouped Into the four categories of clinical normotension; white coat hypertension; ambulatory hypertension, dippers; and ambulatory hypertension, nondippers. Comparison between survival curves was highly significant (P<.002). I approximately 22% of current clinical indications for ambulatory BP monitoring by community- or hospitalbased physicians. 51 The second is the differentiation between dippers and nondippers among women with ambulatory hypertension. A fundamental point of this study, inherent in any observational survey, is the lack of intervention on potentially important confounders, in our case the current medical approach to hypertension. Since the management of hypertensive subjects was based on their clinic BP, the possibility remains that the better prognosis in the white coat group may reflect a superior effect of treatment in these subjects owing, for example, to their lower clinic BP compared with the ambulatory hypertension group. On the other hand, the higher incidence of cardiovascular events in female nondippers could reflect an incomplete control of nighttime BP in these subjects. Nonetheless, these observational data generate two main hypotheses for interventional studies. First, antihypertensive drug treatment might be withheld in subjects with white coat hypertension, particularly when organ lesions or other risk factors are absent. The good prognosis in our subjects with white coat hypertension supports this possibility, but a more detailed background will come from surveys of the natural history of this condition in the very long term. These studies should also compare the response to drug treatment with that to lifestyle measures in these subjects. A cost-effectiveness analysis comparing a single session of ambulatory BP monitoring with repeated standardized BP measurements in the physician's office is also warranted because the accuracy of the latter procedure may be comparable with that of ambulatory BP monitoring. 52 Second, an additional new goal of antihypertensive treatment might become the reduction of increased nighttime BP. The high incidence of cardiovascular morbid events in female nondippers with ambulatory hypertension suggests the potential utility of a more aggressive therapeutic approach for these subjects whose status of nondippers carries an independent risk for future cardiovascular events. In this setting, ambulatory BP monitoring seems to be the only practical way to detect nighttime BP. Acknowledgments This work was supported in part by grants provided by the Associazione Umbra Cuore e Ipertensione, Perugia, Italy. We are indebted to the staff of the Medical Department of CIBA-GEIGY, Origgio, Italy, for providing technical support. References 1. Rowlands DB, Glover DR, Ireland MA, McLeay RAB, Stallard TJ, Watson RDS, Littler WA. Assessment of left ventricular mass and its response to antihypertensive treatment. Lancet. 1982; 1: Drayer JIM, Weber MA, DeYoung JL. BP as a determinant of cardiac left ventricular muscle mass. Arch Intern Med. 1983;143: Devereux RB, Pickering TG, Harshfield GA, Kleinert HD, Denby L, Clark L, Pregibon D, Jason M, Kleiner B, Borer J, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation. 1983;68: Verdecchia P, Schillaci G, Boldrini F, Guerrieri M, Gatteschi C, Benemio G, Porcellati C. Risk stratification of left ventricular hypertrophy in systemic hypertension using noninvasive ambulatory blood pressure monitoring. Am J Cardwl. 1990;66: Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target organ damage in hypertension. J Hypertens. 1987;5:93-98.
9 Verdecchia et al Prognostic Value of Ambulatory Blood Pressure Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M, Pessina AC. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med. 1992; 152: Sokolow M, Pcrloff DB. The prognosis of essential hypertension treated conservatively. Circulation. 1961;23: Kannel WB. Role of blood pressure in cardiovascular morbidity and mortality. Prog Cardiovasc Dis. 1974; 17: The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chronic Dis. 1978;31:20l Kannel WB, Doyle JT, Ostfeld AM, Jenkins CD, Kuller L, Podell RN, Stamler J. Optimal resources of primary prevention of atherosclerotic diseases. Circulation. 1984;70:157A-205A. 11. Breslin DJ, Gilford RW Jr, Fairbairn JF II. Essential hypertension: a twenty-one year follow-up study. Circulation. 1966;33: Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105: Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. Ann Intern Med. 1989;110: Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990;322: Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114: Mensah GA, Koren MJ, Ulin R, Pappas TW, Nicholson J, Laragh JH, Devereux RB. Comparison of classification of the severity of hypertension by blood pressure level and by World Health Organization criteria in the prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension. J Hypertens. 1993;11: Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure. JAMA. 1983;249: Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens. 1989;7(suppl 3):S3-SI Lang RM, Borow KM, Weinert L, Bednarz J, Neumann A, Nelson K, David D, Murphy MB. Circadian blood pressure patterns in hypertensive patients: importance of nocturnal blood pressure. Circulation. 1988;78(suppl II):II-517. Abstract. 20. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81: Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens. 1992;10: Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens. 1992;5: Kobrin I, Oigman W, Kumar A, Ventura HO, Messerli FH, Frohlich ED, Dunn FG. Diurnal variation of blood pressure in elderly patients with essential hypertension. J Am Geriatr Soc. 1984;32: Verdecchia P, Schillaci G, Gatteschi C, Zampi I, Battistelli M, Bartoccini C, Porcellati C. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation. 1993;88: O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988;2: Verdecchia P, Schillaci G, Boldrini F, Guerrieri M, Zampi I, Porcellati C. Quantitative assessment of day-to-day spontaneous variability in non-invasive ambulatory blood pressure measurements in essential hypertension. J Hypertens. 1991;9(suppl 6):S322-S Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C. Variability between current definitions of 'normal' ambulatory blood pressure: implications in the assessment of white coat hypertension. Hypertension. 1992;20: Verdecchia P, Schillaci G, Boldrini F, Guerrieri M, Porcellati C. Sex, cardiac hypertrophy and diurnal blood pressure variations in essential hypertension. J Hypertens. 1992; 10: Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57: Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation. 1987;75: Kaplan ER, Meier P. Nonparametric estimation from incomplete observations. J Am Slat Assoc. 1958;53: Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50: Cox DR. Regression models and life-tables. J R Slat Soc B. 1972;34: Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariate models. Ann Intern Med. 1993;118: Mancia G, Parati G. Clinical significance of 'white coat' hypertension. Hypertension. 1990;16: Pickering TG. Clinic measurement of blood pressure and white-coat hypertension. In: Pickering TG, ed. Ambulatory Monitoring and Blood Pressure Variability. London, UK: Science Press Ltd, 1991: Mancia G, Bertineri G, Grassi G, Parati G, Pomidossi G, Ferrari A, Gregorini L, Zanchetti A. Effects of blood pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet. 1983;2: Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white-coat hypertension? JAMA. 1988;259: Julius S, Mejis A, Kones K, Krause L, Schork N, van de Ven C, Johnson E, Petrin J, Sekkarie A, Kjeldsen SE, et al. 'White coat' versus 'sustained' borderline hypertension in Tecumseh, Michigan. Hypertension. 1990;16: Staessen JA, Fagard RH, Lijnen Thijs L, Van Hoof R, Amery AK. Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol. 1991;67: White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure, not office pressure, determines cardiac function in patients with hypertension. JAMA. 1989;261: Hoegholm A, Kristensen KS, Bang LE, Nielsen JW, Nielsen WB, Madsen NH. Left ventricular mass and geometry in patients with established hypertension and white-coat hypertension. Am J Hypertens. 1993;6: Cardillo C, De Felice F, Campia U, Folli G. Psychophysiological reactivity and cardiac end-organ changes in white-coat hypertension. Hypertension. 1993;21: Madhavan S, Lock Ooi W, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23: Pickering TG, James GD. Determinants and consequences of the diurnal rhythm of blood pressure. Am J Hypertens. 1993;6:166S-169S. 46. Rockstroh JK, Schmieder RE, Gatzka C, Messerli FH. Relation of circadian blood pressure changes to left ventricular hypertrophy in essential hypertension. Am J Hypertens. 1992;5:26A. Abstract. 47. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, Pessina AC, De Cesaris R, Fogari R, Libretti A, Porcellati C, Verdecchia P, et al. Prognostic value of ambulatory blood pressure: the SAMPLE study. High Blood Pressure. 1992;l: The National High Blood Pressure Education Program Coordinating Committee. National high blood pressure education program working group report on ambulatory blood pressure monitoring. Arch Intern Med. 1990;150: Appel LJ, Stason WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med. 1993;118: American College of Physicians. Automated ambulatory blood pressure and self-measured blood pressure monitoring devices: their role in the diagnosis and management of hypertension. Ann Intern Med. 1993; 118: Grin JM, McCabe EJ, White WB. Management of hypertension after ambulatory blood pressure monitoring. Ann Intern Med. 1993;118: Pearce KA, Grimm RH, Rao S, Svendsen K, Liebson PR, Neaton JD, Ensrud K. Population-derived comparisons of ambulatory and office blood pressures. Arch Intern Med. 1992;152:
Ambulatory Blood Pressure. An Independent Predictor of Prognosis in Essential Hypertension
793 Ambulatory Blood Pressure An Independent Predictor of Prognosis in Essential Hypertension Paolo Verdecchia, Carlo Porcellati, Giuseppe Schillaci, Claudia Borgioni, Antonella Ciucci, Massimo Battistelli,
More informationPrognostic Value of a New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension
JACC Vol. 31, No. 2 February 1998:383 90 383 Prognostic Value of a New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension PAOLO VERDECCHIA, MD, GIUSEPPE
More informationThe most important risk factors for atrial fibrillation (AF)
Atrial Fibrillation in Hypertension Predictors and Outcome Paolo Verdecchia, GianPaolo Reboldi, Roberto Gattobigio, Maurizio Bentivoglio, Claudia Borgioni, Fabio Angeli, Erberto Carluccio, Maria Grazia
More informationDoes the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
(24) 18, S23 S28 & 24 Nature Publishing Group All rights reserved 95-92/4 $3. www.nature.com/jhh ORIGINAL ARTICLE Does the reduction in systolic blood pressure alone explain the regression of left ventricular
More informationPrognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice
(2005) 19, 801 807 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured in the office, at home and
More informationPrevalence of left ventricular hypertrophy in a hypertensive population
European Heart Journal (1996) 17, 143-149 Prevalence of left ventricular hypertrophy in a hypertensive population J. Tingleff, M. Munch, T. J. Jakobsen, C. Torp-Pedersen, M. E. Olsen, K. H. Jensen, T.
More informationPulse pressure (PP) is a well-established marker of cardiovascular
Different Prognostic Impact of 24-Hour Mean Blood Pressure and Pulse Pressure on Stroke and Coronary Artery Disease in Essential Hypertension Paolo Verdecchia, MD; Giuseppe Schillaci, MD; Gianpaolo Reboldi,
More informationNocturnal Blood Pressure in Treated Hypertensive African Americans Compared to Treated Hypertensive European Americans1
Nocturnal Blood Pressure in Treated Hypertensive African Americans Compared to Treated Hypertensive European Americans1 Lee A. Hebert,2 Garima Agarwal, Stephanie E. Ladson-Wofford, Max Reif, Leena Hiremath,
More informationThe hypothesis that left ventricular hypertrophy (LVH) Regression of Left Ventricular Hypertrophy and Prevention of Stroke in Hypertensive Subjects
AJH 2006; 19:493 499 Heart Regression of Left Ventricular Hypertrophy and Prevention of Stroke in Hypertensive Subjects Paolo Verdecchia, Fabio Angeli, Roberto Gattobigio, Mariagrazia Sardone, Sergio Pede,
More informationDIURNAL VARIATIONS IN BLOOD PRESSURE AND THEIR RELATION WITH CAROTID ARTERY INTIMA-MEDIA THICKENING
DIURNAL VARIATIONS IN BLOOD PRESSURE AND THEIR RELATION WITH CAROTID ARTERY INTIMA-MEDIA THICKENING Sh Narooei (1), B Soroor (2), F Zaker (3) Abstract INTRODUCTION: Hypertension is a very common cardiovascular
More informationDr. A. Manjula, No. 7, Doctors Quarters, JLB Road, Next to Shree Guru Residency, Mysore, Karnataka, INDIA.
Original Article In hypertensive patients measurement of left ventricular mass index by echocardiography and its correlation with current electrocardiographic criteria for the diagnosis of left ventricular
More informationComparison of arbitrary definitions of circadian time periods with those determined by wrist actigraphy in analysis of ABPM data
Journal of Human Hypertension (1999) 13, 449 453 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Comparison of arbitrary definitions of
More informationANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*
Progress in Clinical Medicine 1 ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION* Keishi ABE** Asian Med. J. 44(2): 83 90, 2001 Abstract: J-MUBA was a large-scale clinical
More informationClinic blood pressure (BP) is greater than ambulatory or
Attenuation of the White-Coat Effect by Antihypertensive Treatment and Regression of Target Organ Damage Gianfranco Parati, Luisa Ulian, Lorena Sampieri, Paolo Palatini, Alessandra Villani, Alessandro
More informationDIFFERENTE RELAZIONE TRA VALORI PRESSORI E MASSA VENTRICOLARE SX NEI DUE SESSI IN PAZIENTI IPERTESI.
DIFFERENTE RELAZIONE TRA VALORI PRESSORI E MASSA VENTRICOLARE SX NEI DUE SESSI IN PAZIENTI IPERTESI. Franco Cipollini, Carlo Porta, Enrica Arcangeli, Carla Breschi, & Giuseppe Seghieri Azienda USL 3, Ambulatorio
More informationHow well do office and exercise blood pressures predict sustained hypertension? A Dundee Step Test Study
(2000) 14, 429 433 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh ORIGINAL ARTICLE How well do office and exercise blood pressures predict sustained hypertension?
More informationShould all patients with hypertension have echocardiography?
(2000) 14, 417 421 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh REVIEW ARTICLE Should all patients with hypertension have echocardiography? G de Simone 1,2,
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationPrognostic Significance of Left Ventricular Diastolic Dysfunction in Essential Hypertension
Journal of the American College of Cardiology Vol. 39, No. 12, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01896-X
More informationEchocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass?
Journal of Human Hypertension (1999) 13, 505 509 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Echocardiographic definition of left ventricular
More informationWhite-coat hypertension (WCH), 1 referred to as office 2
Short- and Long-Term Incidence of Stroke in White-Coat Hypertension Paolo Verdecchia, Gian Paolo Reboldi, Fabio Angeli, Giuseppe Schillaci, Joseph E. Schwartz, Thomas G. Pickering, Yutaka Imai, Takayoshi
More informationPrognostic significance of blood pressure measured on rising
(2001) 15, 413 417 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured on rising P Gosse, C Cipriano,
More informationOver the last 50 years, it has become increasingly recognized
Prediction of Coronary and Cerebrovascular Morbidity and Mortality by Direct Continuous Ambulatory Blood Pressure Monitoring in Essential Hypertension Rajdeep S. Khattar, BM, MRCP; John D. Swales, MA,
More informationAngiotensin II Receptor Blocker Telmisartan: Effect on Blood Pressure Profile and Left Ventricular Hypertrophy in Patients with Arterial Hypertension*
The Journal of International Medical Research 2005; 33 (Suppl 1): 21A 29A Angiotensin II Receptor Blocker Telmisartan: Effect on Blood Pressure Profile and Left Ventricular Hypertrophy in Patients with
More informationRegression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol
Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol The Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study Peter M. Okin, MD; Richard B. Devereux,
More informationORIGINAL INVESTIGATION. High-Normal Serum Creatinine Concentration Is a Predictor of Cardiovascular Risk in Essential Hypertension
ORIGINAL INVESTIGATION High-Normal Serum Creatinine Concentration Is a Predictor of Cardiovascular Risk in Essential Hypertension Giuseppe Schillaci, MD; Gianpaolo Reboldi, MD, MSc, PhD; Paolo Verdecchia,
More informationBRIEF COMMUNICATIONS. KEY WORDS: Ambulatory blood pressure monitoring, placebo effect, antihypertensive drug trials.
AJH 1995; 8:311-315 BRIEF COMMUNICATIONS Lack of Placebo Effect on Ambulatory Blood Pressure Giuseppe Mancia, Stefano Omboni, Gianfranco Parati, Antonella Ravogli, Alessandra Villani, and Alberto Zanchetti
More informationThe Framingham Heart Study has recently
AJH 1997;10:836 842 Influence of Nighttime Blood Pressure on Left Atrial Size in Uncomplicated Arterial Systemic Hypertension Maurizio Galderisi, Antonio Petrocelli, Ayman Fakher, Annibale Izzo, Alfonso
More informationFOR many years, casual blood pressure (BP)
What Is the Value of Home Blood Pressure Measurement in Patients with Mild Hypertension? HOLLIS D. KLEINERT, GREGORY A. HARSHFIELD, THOMAS G. PICKERING, RICHARD B. DEVEREUX, PATRICIA A. SULLIVAN, ROSE
More informationHigh-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study
22 High- Blood Pressure Progression to Hypertension in the Framingham Heart Study Mark Leitschuh, L. Adrienne Cupples, William Kannel, David Gagnon, and Aram Chobanian This study sought to determine if
More informationOBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS
Journal of the American College of Cardiology Vol. 38, No. 1, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01325-0 Silent
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationPrognostic Value of Different Indices of Blood Pressure Variability in Hypertensive Patients
articles nature publishing group Prognostic Value of Different Indices of Blood Pressure Variability in Hypertensive Patients Sante D. Pierdomenico 1,2, Marta Di Nicola 3, Anna L. Esposito 3, Rocco Di
More informationSlide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More informationNight time blood pressure and cardiovascular structure in a middle-aged general population in northern Italy: the Vobarno Study
(2001) 15, 879 885 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Night time blood pressure and cardiovascular structure in a middle-aged general
More informationHospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension
(2003) 17, 665 670 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Hospital and 1-year outcome after acute myocardial infarction in patients with
More informationYOUNG ADULT MEN AND MIDDLEaged
BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,
More informationCombined Echocardiographic Left Ventricular Hypertrophy and Electrocardiographic ST Depression Improve Prediction of Mortality in American Indians
Combined Echocardiographic Left Ventricular Hypertrophy and Electrocardiographic ST Depression Improve rediction of Mortality in American Indians The Strong Heart Study eter M. Okin, Mary J. Roman, Elisa
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationAmbulatory Blood Pressure and Cardiovascular Events in Chronic Kidney Disease. Rajiv Agarwal, MD
Ambulatory Blood Pressure and Cardiovascular Events in Chronic Kidney Disease Rajiv Agarwal, MD Summary: Hypertension is an important risk factor for adverse cardiovascular and renal outcomes, particularly
More informationCLINICAL SCIENCE. Angela M. G. Pierin a, Edna C. Ignez a, Wilson Jacob Filho b, Alfonso Júlio Guedes Barbato b, Décio Mion Jr. b
CLINICS 2008;63(1):43-50 CLINICAL SCIENCE BLOOD PRESSURE MEASUREMENTS TAKEN BY PATIENTS ARE SIMILAR TO HOME AND AMBULATORY BLOOD PRESSURE MEASUREMENTS Angela M. G. Pierin a, Edna C. Ignez a, Wilson Jacob
More informationHypertension Compendium
Hypertension Compendium Circulation Research Compendium on Hypertension The Epidemiology of Blood Pressure and Its Worldwide Management Genetic and Molecular Aspects of Hypertension Hypertension: Renin
More informationThe incidence of transient myocardial ischemia,
AJH 1999;12:50S 55S Heart Rate and the Rate-Pressure Product as Determinants of Cardiovascular Risk in Patients With Hypertension William B. White Inability to supply oxygen to the myocardium when demand
More informationMareomi Hamada, Go Hiasa, Osamu Sasaki, Tomoaki Ohtsuka, Hidetoshi Shuntaro Ikeda, Makoto Suzuki, Yuji Hara, and Kunio Hiwada
297 Original Article Serum Creatinine Level Renal Involvement Essential Underestimates Hypertensive in Elderly Patients with Hypertension Yuji Shigematsu, Mareomi Hamada, Go Hiasa, Osamu Sasaki, Tomoaki
More informationImportance of Ambulatory Blood Pressure Monitoring in Adolescents
Importance of Ambulatory Blood Pressure Monitoring in Adolescents Josep Redon, MD, PhD, FAHA Internal Medicine Hospital Clinico Universitario de Valencia University of Valencia CIBERObn Instituto de Salud
More informationDespite the growing body of evidence supporting the
Sleep and Ambulatory Blood Pressure Ambulatory Blood Pressure and Cardiovascular Outcome in Relation to Perceived Sleep Deprivation Paolo Verdecchia, Fabio Angeli, Claudia Borgioni, Roberto Gattobigio,
More informationJournal of the American College of Cardiology Vol. 41, No. 6, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 41, No. 6, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Science Inc. doi:10.1016/s0735-1097(03)00052-4
More informationOverview of the outcome trials in older patients with isolated systolic hypertension
Journal of Human Hypertension (1999) 13, 859 863 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Overview of the outcome trials in older patients with isolated
More informationComparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study
80 Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study Thomas Truelsen, MB; Ewa Lindenstrtfm, MD; Gudrun Boysen, DMSc Background and Purpose We wished to
More informationAGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK. Michael Smolensky, Ph.D. The University of Texas Austin & Houston
AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK Michael Smolensky, Ph.D. The University of Texas Austin & Houston Disclosures Partner: Circadian Ambulatory Diagnostics Consultant: Spot On Sciences
More informationShougo Murakami, Kuniaki Otsuka, Yutaka Kubo, Makoto Shinagawa, Takashi Yamanaka, Shin-ichiro Ohkawa, and Yasushi Kitaura
AJH 2004; 17:1179 1183 Repeated Ambulatory Monitoring Reveals a Monday Morning Surge in Blood Pressure in a Community-Dwelling Population Shougo Murakami, Kuniaki Otsuka, Yutaka Kubo, Makoto Shinagawa,
More informationThe problem of uncontrolled hypertension
(2002) 16, S3 S8 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh The problem of uncontrolled hypertension Department of Public Health and Clinical Medicine, Norrlands
More informationPrevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient
Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient The Issue of Primary Prevention of A.Fib. (and Heart Failure) and not the Prevention of Recurrent A.Fib. after Electroconversion
More informationDiurnal Variations of Blood Pressure and Microalbuminuria in Essential Hypertension
A] H 1994;7:23-29 Diurnal Variations of Blood Pressure and Microalbuminuria in Essential Hypertension Stefano Bianchi, Roberto Bigazzi, Giorgio Balàari, Gianpaolo Sgherri, and Vito M. Campese The extensive
More informationAmbulatory Blood Pressure Monitoring. Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension Prognostic Implications
Ambulatory Blood Pressure Monitoring Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension Prognostic Implications Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Marta Garofoli, Elisa
More informationLeft ventricular mass in offspring of hypertensive parents: does it predict the future?
ISPUB.COM The Internet Journal of Cardiovascular Research Volume 7 Number 1 Left ventricular mass in offspring of hypertensive parents: does it predict the future? P Jaiswal, S Mahajan, S Diwan, S Acharya,
More informationORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods
Vol. 2, Issue 1, pages 31-36 ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY By Alejandro de la Sierra, MD Luis M. Ruilope, MD Hypertension Units, Hospital Clinico, Barcelona & Hospital 12 de Octubre,
More informationLeft ventricular hypertrophy (LVH) carries a substantial
New Gender-Specific Partition Values for ECG Criteria of Left Ventricular Hypertrophy Recalibration Against Cardiac MRI Khaled Alfakih, Kevin Walters, Tim Jones, John Ridgway, Alistair S. Hall, Mohan Sivananthan
More informationAn Observational Study: Ambulatory Blood Pressure Monitoring after Percutaneous Transluminal Coronary Angioplasty
THIEME Original Article 17 An Observational Study: Ambulatory Blood Pressure Monitoring after Percutaneous Transluminal Coronary Angioplasty Gopi Krishna Kenchi 1 Sunisha Gajula 2 Malleshwar Rao Dangati
More informationHypertension in the Elderly
CardioCase of the Month Hypertension in the Elderly By Luc Trudeau, MD CardioCase Presentation Case Facts Georges is a 63-year-old retired civil servant. He stopped smoking 10 years ago. He denies experiencing
More informationLEFT VENTRICULAR HYPERTROPHY AND CLINICAL OUTCOME IN CAPD PATIENTS
Peritoneal Dialysis International, Vol. 20, pp. 461 466 Printed in Canada. All rights reserved. 0896-8608/00 $3.00 +.00 Copyright 2000 International Society for Peritoneal Dialysis LEFT VENTRICULAR HYPERTROPHY
More informationAmbulatory blood pressure monitoring has shown that in
Difference Between Clinic and Daytime Blood Pressure Is Not a Measure of the White Coat Effect Gianfranco Parati, Luisa Ulian, Cinzia Santucciu, Stefano Omboni, Giuseppe Mancia Abstract The purpose of
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular
More informationTwenty-Four Hour Blood Pressure Profile in Subjects with Different Subtypes of Primary Aldosteronism
Physiol. Res. 50: 51-57, 2001 Twenty-Four Hour Blood Pressure Profile in Subjects with Different Subtypes of Primary Aldosteronism T. ZELINKA, J. WIDIMSKÝ Third Medical Department, First Medical School
More informationPreventing the cardiovascular complications of hypertension
European Heart Journal Supplements (2004) 6 (Supplement H), H37 H42 Preventing the cardiovascular complications of hypertension Peter Trenkwalder* Department of Internal Medicine, Starnberg Hospital, Ludwig
More informationThe Whitehall II study originally comprised 10,308 (3413 women) individuals who, at
Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.
More informationAbody of evidence demonstrates that alcohol
BRIEF COMMUNICATIONS AJH 1998;11:230 234 The Effects of Alcohol Consumption on Ambulatory Blood Pressure and Target Organs in Subjects With Borderline to Mild Hypertension Olga Vriz, Diana Piccolo, Enrico
More informationGender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients
CLINICAL STUDY Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients Joji Ishikawa, 1 MD, Yuko Yamanaka, 2 MD, Ayumi Toba, 1 MD, Shintaro Watanabe, 3 MD and Kazumasa
More informationBlood Pressure Targets in Diabetes
Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet
More informationCirculation. 2009;119: ; originally published online March 30, 2009; doi: /CIRCULATIONAHA
Prognostic Value of Changes in the Electrocardiographic Strain Pattern During Antihypertensive Treatment: The Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE) Peter M. Okin, Lasse
More informationCandesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
1/5 This site became the new ClinicalTrials.gov on June 19th. Learn more. We will be updating this site in phases. This allows us to move faster and to deliver better services. Show less IMPORTANT: Listing
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life
More informationAmbulatory blood pressure (ABP) may be normal in
Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension Robert H. Fagard, MD; Jan A. Staessen, MD; Lutgarde Thijs, BSc; Jerzy Gasowski, MD; Christopher
More informationBody Mass Index and Blood Pressure Influences on Left Ventricular Mass and Geometry in African Americans
Body Mass Index and Blood Pressure Influences on Left Ventricular Mass and Geometry in African Americans The Atherosclerotic Risk In Communities (ARIC) Study Ervin Fox, Herman Taylor, Michael Andrew, Hui
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationHow Low Do We Go? Update on Hypertension
How Low Do We Go? Update on Beth L. Abramson, MD, FRCPC, FACC As presented at the University of Toronto s Saturday at the University Session (September 2003) Arecent World Health Organization report states
More informationRegression of left ventricular hypertrophy: lessons from clinical trials
Page 1 of 8 Systematic s Regression of left ventricular hypertrophy: lessons from clinical trials P Pokharel 1, JN Bella 1,2 * Abstract Introduction Hypertension is an epidemic that affects more than 1
More informationJournal of the American College of Cardiology Vol. 50, No. 11, by the American College of Cardiology Foundation ISSN /07/$32.
Journal of the American College of Cardiology Vol. 50, No. 11, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.05.035
More informationSTANDARD ELECTROCARDIOGRAPHIC CRITERIA FOR LEFT VENTRICULAR HYPERTROPHY
STANDARD ELECTROCARDIOGRAPHIC CRITERIA FOR LEFT VENTRICULAR HYPERTROPHY IN NIGERIAN HYPERTENSIVES Objectives: Left ventricular hypertrophy (LVH) is a major risk factor for cardiovascular morbidity and
More informationS. Majahalme 1, V. Turjanmaa 2;3, A. B. Weder 4,H.Lu 5, M. Tuomisto 2 and A. Uusitalo 2;3
Of ce and laboratory blood pressures as predictors of daily blood pressure level in normotensive subjects and borderline and mild hypertensive subjects S. Majahalme 1, V. Turjanmaa 2;3, A. B. Weder 4,H.Lu
More informationORIGINAL INVESTIGATION. Calcium Antagonists and Mortality Risk in Men and Women With Hypertension in the Framingham Heart Study
ORIGINAL INVESTIGATION s and Mortality Risk in Men and Women With Hypertension in the Framingham Heart Study Vivian M. Abascal, MD; Martin G. Larson, ScD; Jane C. Evans, MPH; Ana T. Blohm, BA; Kim Poli,
More informationThe classic strain pattern of ST depression and T-wave
Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Peter M.
More informationOriginal Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit
98 Original Contributions Prospective Comparison of a Cohort With Carotid Bruit and a Population-Based Cohort Without Carotid Bruit David O. Wiebers, MD, Jack P. Whisnant, MD, Burton A. Sandok, MD, and
More informationAmbulatory blood pressure measurement is now indispensable to the good clinical management of hypertension
CARDIOVASCULAR JOURNAL OF SOUTH AFRICA Vol 14, No. 3, May/June 2003 113 Editorial Ambulatory blood pressure measurement is now indispensable to the good clinical management of hypertension Ambulatory blood
More informationHow do we diagnose hypertension today? Presentation Subtitle
How do we diagnose hypertension today? Presentation Subtitle Renata Cífková Case 1 JM, a 64-year-old lady referred to our center because of undesirable effects of her antihypertensive medication Personal
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationPRELIMINARY STUDIES OF LEFT VENTRICULAR WALL THICKNESS AND MASS OF NORMOTENSIVE AND HYPERTENSIVE SUBJECTS USING M-MODE ECHOCARDIOGRAPHY
Malaysian Journal of Medical Sciences, Vol. 9, No. 1, January 22 (28-33) ORIGINAL ARTICLE PRELIMINARY STUDIES OF LEFT VENTRICULAR WALL THICKNESS AND MASS OF NORMOTENSIVE AND HYPERTENSIVE SUBJECTS USING
More informationa Hypertension and Cardiovascular Rehabilitation Unit, Faculty of Medicine, Received 2 June 2008 Revised 1 July 2008 Accepted 9 July 2008
Original article 325 Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease Robert H. Fagard a, Lutgarde Thijs a, Jan A. Staessen a, Denis
More informationMany observational studies evaluating the changing pattern
Effect of Aging on the Prognostic Significance of Ambulatory Systolic, Diastolic, and Pulse Pressure in Essential Hypertension Rajdeep S. Khattar, BM, MRCP; John D. Swales, MA, MD, FRCP; Caroline Dore,
More informationJMSCR Vol 04 Issue 05 Page May 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 5.88 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v4i5.14 Study on ECG Changes in Chronic hypertensive
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic
1 U.S. Department of Health and Human Services National Institutes of Health Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker
More informationInterventricular Septum Thickness Predicts Future Systolic Hypertension in Young Healthy Pilots
15 Original Article Hypertens Res Vol.31 (2008) No.1 p.15-20 Interventricular Septum Thickness Predicts Future Systolic Hypertension in Young Healthy Pilots Chagai GROSSMAN 1), Alon GROSSMAN 2), Nira KOREN-MORAG
More informationLarge therapeutic studies in elderly patients with hypertension
(2002) 16 (Suppl 1), S38 S43 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh Large therapeutic studies in elderly patients with hypertension Centro Clinico Profesional
More informationObservational, population-based studies demonstrate that
Systolic Blood Pressure Control and Mortality After Stroke in Hypertensive Patients Peter M. Okin, MD; Sverre E. Kjeldsen, MD; Richard B. Devereux, MD Background and Purpose Hypertensive patients with
More informationCombined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women
European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular
More informationIn white mild to moderate hypertensive patients. Nifedipine Versus Captopril in the Management of Moderate Hypertension in Black ratients
A]H 1994; 7:440^47 Nifedipine Versus Captopril in the Management of Moderate Hypertension in Black ratients John Skoularigis, Leslie Eitzman, Jean Davis, Victor Strugo, and Pinhas Sareli The efficacy of
More information